tiprankstipranks
Trending News
More News >
Immuneering Corp. Class A (IMRX)
:IMRX
US Market

Immuneering (IMRX) Income Statement

Compare
399 Followers

Immuneering Income Statement

Last quarter (Q1 2025), Immuneering's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Immuneering's net income was $-15.05M. See Immuneering’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 316.95K$ 2.08M$ 2.31M
Gross Profit
$ 0.00$ -764.14K$ 158.83K$ 926.89K$ 1.03M
Operating Expenses
$ 64.07M$ 57.65M$ 51.90M$ 34.81M$ 18.11M
Depreciation and Amortization
$ 385.07K$ 352.08K$ 796.79K$ 159.07K$ 79.31K
EBITDA
$ -63.69M$ -58.06M$ -51.47M$ -33.68M$ -17.00M
Operating Income
$ -64.07M$ -58.41M$ -51.74M$ -33.89M$ -17.08M
Other Income/Expenses
$ 3.04M$ 4.94M$ 1.23M$ 42.84K$ 42.66K
Pretax Income
$ -61.04M$ -53.47M$ -50.51M$ -33.84M$ -17.04M
Net Income
$ -61.04M$ -53.47M$ -49.28M$ -33.54M$ -17.04M
Per Share Metrics
Basic EPS
$ -2.04$ -1.88$ -1.87$ -1.27$ -0.67
Diluted EPS
$ -2.04$ -1.88$ -1.87$ -1.27$ -0.67
Weighted Average Shares Outstanding
29.98M 28.42M 26.39M 26.32M 25.51M
Weighted Average Shares Outstanding (Diluted)
29.98M 28.42M 26.39M 26.32M 25.51M
Currency in USD

Immuneering Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis